January 30th, 2021

Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment of Soft Tissue Sarcoma (STS)

Immunicum AB (publ; IMMU.ST) announced today that it has received Orphan Drug Designation (ODD) from the U.S. Food and Drug…

Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in…

January 27th, 2021

We are 11 days from Chondrosarcoma Awareness Day. If you have not already done this, we are counting on you to do the following:

1. Get the Word Out. Join us in our efforts to educate the public about Chondrosarcoma, a rare bone and soft tissue…

January 24th, 2021

The Chondrosarcoma Awareness Day is getting the attention from many media outlets across the globe. We are doing our best to raise awareness and support for Chondrosarcoma research and clinical trials. Please check out the links…

January 21st, 2021

The Bowie, MD-based Chondrosarcoma CS Foundation, Inc. is launching an international public campaign to raise awareness and support for Chondrosarcoma research and clinical trials. They are proclaiming February 6, 2021, as Chondrosarcoma Awareness…

January 18th, 2021

Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year

SAN DIEGO,…

Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients

Registration-enabling study expected to begin dosing in the second or third quarter of this year Inhibrx, Inc….

January 16th, 2021

Momentum is growing for our international public awareness campaign to support Chondrosarcoma Research and Clinical Trials. As you know Chondrosarcoma Awareness Day is dedicated to honor the legacy of Shayna Elise Kramer who passed away from this…

January 15th, 2021

In the effort to get the word out the Chondrosarcoma Foundation has sent a press release out to many media outlets to initiate an international public awareness campaign to support Chondrosarcoma Research and Clinical Trials. We declare February 6,…

January 9th, 2021

Chondrosarcoma is a rare bone and soft tissue cancer. Estimates are it effects 4,500 worldwide and approximately 650 in the United States each year.

No one knows the origin of Chondrosarcoma or whether a hereditary pre-disposition exists.

There is…